Evaluation and Management of Cardio Toxicity in Oncologic Patients
Sponsor: Tel-Aviv Sourasky Medical Center
Listed as NCT02818517, this observational or N/A phase trial focuses on Heart Failure and remains actively recruiting participants. Sponsored by Tel-Aviv Sourasky Medical Center, it has been updated 11 times since 2016, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2022 — Jul 2024 [monthly]
Recruiting
-
Jan 2021 — Mar 2022 [monthly]
Recruiting
-
Jul 2020 — Jan 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Jan 2020 — Jul 2020 [monthly]
Recruiting
-
Jun 2019 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2017 — Mar 2018 [monthly]
Not Yet Recruiting NA
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tel-Aviv Sourasky Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .